吡喃结构域
炎症体
先天免疫系统
免疫系统
败血症
机制(生物学)
细胞因子
医学
信号转导
调解人
器官功能障碍
生物
调节器
受体
生物信息学
免疫学
免疫
目标2
半胱氨酸蛋白酶1
治疗方法
自噬
模式识别受体
获得性免疫系统
神经科学
发病机制
病理生理学
脂多糖
自身免疫
平衡
评论文章
NFKB1型
双重角色
炎症
作者
Yuhui Ma,Jialei Meng,Fangyuan Sun,Ming Lei
标识
DOI:10.1016/j.cytogfr.2025.09.006
摘要
Sepsis is a life-threatening organ dysfunction triggered by a dysregulated host response to infection, with immune homeostasis imbalance at the core of its pathological mechanism. The NACHT, leucin-rich repeat (LRR) and pyrin domain (PYD)-containing protein 3 (NLRP3) inflammasome, as an innate immune sensor, plays a critical role in the development and progression of sepsis. Upon activation, the NLRP3 inflammasome triggers caspase-1 activation, which mediates the maturation and release of IL-1β and IL-18, as well as pyroptosis. Studies have demonstrated that inhibiting NLRP3 inflammasome activation can significantly alleviate sepsis-associated systemic inflammatory responses and improve prognosis. This review systematically elucidates the pathophysiological mechanisms of sepsis, the activation mechanisms of the NLRP3 inflammasome, and its dual regulatory role in sepsis progression. Moderate NLRP3 activation aids in pathogen clearance, whereas excessive activation exacerbates cytokine storms, leading to multi-organ failure. Finally, we summarize the latest research progress on NLRP3 inhibitors currently in clinical trial stages. This article aims to provide insights for the development of NLRP3-targeted therapeutic drugs for sepsis.
科研通智能强力驱动
Strongly Powered by AbleSci AI